EODData

FRA, 8E8: ELICERA THERAPEUTICS AB

23 Oct 2026
LAST:

0.2215

CHANGE:
 0.01
OPEN:
0.2215
HIGH:
0.2215
ASK:
0.0000
VOLUME:
0
CHG(%):
3.49
PREV:
0.2295
LOW:
0.2215
BID:
0.0000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
23 Oct 260.22150.22150.22150.22150
22 Oct 260.22950.22950.22950.22950
21 Oct 260.22700.22700.22700.22700
20 Oct 260.22600.22700.22600.22700
19 Oct 260.23000.23000.23000.23000
16 Oct 260.23800.23800.23800.23800
15 Oct 260.24600.24600.24600.24600
13 Oct 260.22900.24050.22900.24050
12 Oct 260.21600.21600.21600.21600
09 Oct 260.21750.21750.21600.21600

PROFILE

Name:ELICERA THERAPEUTICS AB
About:Elicera Therapeutics AB (publ), a clinical stage immuno-oncology company, develops cell and gene therapies for immune-based cancer treatments in Sweden. The company's portfolio products in pipeline includes ELC-100 that is in Phase I/IIa clinical trial for neuroendocrine tumors; and ELC-201, which is in preclinical stage for the treatment of various forms of solid cancer. It is also developing ELC-301, a CAR T-cell therapy that is in Phase I/IIa clinical trial for the treatment of Non-Hodgkin's B-cell lymphoma; and ELC-401, a CAR T-cell therapy, which is in preclinical stage for the treatment of brain tumors. Elicera Therapeutics AB (publ) has collaboration with the Vecura R&D division at Karolinska University Hospital and Uppsala University to develop a fully automated production flow of ELC-401 for use in future clinical trials. The company was incorporated in 2014 and is based in Gothenburg, Sweden.
Sector:Healthcare
Industry:Biotechnology
Address:World Trade Center Göteborg, Gothenburg, Sweden, 412 51
Website:https://www.elicera.com

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:-0.63 
PEG Ratio:-0.01 
Price to Sales:4.62 
Price to Book:0.35 
Profit Margin:-2.31 
Operating Margin:-1.07 
Return on Assets:-0.23 
Return on Equity:-0.42 
Revenue:546.9K 
Shares:48.54M 
Market Cap:10.75M 

TECHNICAL INDICATORS

MA5:0.232.5%
MA10:0.233.5%
MA20:0.220.5%
MA50:0.220.4%
MA100:0.222.1%
MA200:0.3347.2%
STO9:18.33 
STO14:18.33 
RSI14:49.38
WPR14:-81.67 
MTM14:0.00
ROC14:-0.01 
ATR:0.01 
Week High:0.247.4%
Week Low:0.220.0%
Month High:0.2511.1%
Month Low:0.2147.2%
Year High:0.61173.1%
Year Low:0.1824.0%
Volatility:13.76